Institute of Human Virology, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Biochemistry. 2013 Mar 5;52(9):1547-58. doi: 10.1021/bi301008r. Epub 2013 Feb 21.
Cathelicidins form a family of small host defense peptides distinct from another class of cationic antimicrobial peptides, the defensins. They are expressed as large precursor molecules with a highly conserved pro-domain known as the cathelin-like domain (CLD). CLDs have high degrees of sequence homology to cathelin, a protein isolated from pig leukocytes and belonging to the cystatin family of cysteine protease inhibitors. In this report, we describe for the first time the X-ray crystal structure of the human CLD (hCLD) of the sole human cathelicidin, LL-37. The structure of the hCLD, determined at 1.93 Å resolution, shows the cystatin-like fold and is highly similar to the structure of the CLD of the pig cathelicidin, protegrin-3. We assayed the in vitro antibacterial activities of the hCLD, LL-37, and the precursor form, pro-cathelicidin (also known as hCAP18), and we found that the unprocessed protein inhibited the growth of Gram-negative bacteria with efficiencies comparable to that of the mature peptide, LL-37. In addition, the antibacterial activity of LL-37 was not inhibited by the hCLD intermolecularly, because exogenously added hCLD had no effect on the bactericidal activity of the mature peptide. The hCLD itself lacked antimicrobial function and did not inhibit the cysteine protease, cathepsin L. Our results contrast with previous reports of hCLD activity. A comparative structural analysis between the hCLD and the cysteine protease inhibitor stefin A showed why the hCLD is unable to function as an inhibitor of cysteine proteases. In this respect, the cystatin scaffold represents an ancestral structural platform from which proteins evolved divergently, with some losing inhibitory functions.
抗菌肽 cathelicidins 构成了一个独特的宿主防御小肽家族,与另一类阳离子抗菌肽 defensins 不同。它们作为具有高度保守前导域的大型前体分子表达,该前导域称为 cathelin 样结构域(CLD)。CLD 与 cathelin 具有高度的序列同源性,cathelin 是一种从猪白细胞中分离出来的蛋白,属于半胱氨酸蛋白酶抑制剂的半胱氨酸蛋白酶抑制剂家族。在本报告中,我们首次描述了唯一的人类抗菌肽 LL-37 的人 CLD(hCLD)的 X 射线晶体结构。该 hCLD 的结构在 1.93Å 的分辨率下确定,显示出半胱氨酸蛋白酶抑制剂样折叠,与猪 cathelicidin protegrin-3 的 CLD 结构高度相似。我们检测了 hCLD、LL-37 和前体形式 pro-cathelicidin(也称为 hCAP18)的体外抗菌活性,发现未加工的蛋白抑制革兰氏阴性菌的生长效率与成熟肽 LL-37 相当。此外,LL-37 的抗菌活性不受 hCLD 分子间的抑制,因为外源添加的 hCLD 对成熟肽的杀菌活性没有影响。hCLD 本身没有抗菌功能,也不能抑制半胱氨酸蛋白酶 cathepsin L。我们的结果与之前关于 hCLD 活性的报告形成对比。hCLD 和半胱氨酸蛋白酶抑制剂 stefin A 之间的比较结构分析表明,为什么 hCLD 不能作为半胱氨酸蛋白酶抑制剂发挥作用。在这方面,半胱氨酸蛋白酶抑制剂支架代表了一个祖先的结构平台,从这个平台上,蛋白质以不同的方式进化,其中一些失去了抑制功能。